Cargando…

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells

Detalles Bibliográficos
Autores principales:	Wiersma, Valerie R, de Bruyn, Marco, van Ginkel, Robert J, Sigar, Emily, Hirashima, Mitsuomi, Niki, Toshiro, Nishi, Nozomu, Samplonius, Douwe F, Helfrich, Wijnand, Bremer, Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422695/ https://www.ncbi.nlm.nih.gov/pubmed/22572821 http://dx.doi.org/10.1038/jid.2012.133

Ejemplares similares

Galectin-9 Activates and Expands Human T-Helper 1 Cells
por: Gooden, Marloes J. M., et al.
Publicado: (2013)

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux
por: Wiersma, Valerie R, et al.
Publicado: (2015)

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
por: Hendriks, Djoke, et al.
Publicado: (2016)

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
por: Bremer, Edwin, et al.
Publicado: (2008)

Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3(+) Treg Development by Galectin-9 Secretion
por: Oomizu, Souichi, et al.
Publicado: (2012)

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance
por: Choukrani, Ghizlane, et al.
Publicado: (2023)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
por: He, Yuan, et al.
Publicado: (2017)

Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
por: Madireddi, Shravan, et al.
Publicado: (2014)

The Ever-Expanding Immunomodulatory Role of Calreticulin in Cancer Immunity
por: de Bruyn, Marco, et al.
Publicado: (2015)

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
por: van Bommel, Peter E., et al.
Publicado: (2017)

Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity
por: Ustyanovska Avtenyuk, Natasha, et al.
Publicado: (2021)

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
por: Keryer-Bibens, Cécile, et al.
Publicado: (2006)

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production
por: Horio, Yuko, et al.
Publicado: (2017)

Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3
por: Moritoki, Masahiro, et al.
Publicado: (2013)

Galectin-9 Enhances Cytokine Secretion, but Suppresses Survival and Degranulation, in Human Mast Cell Line
por: Kojima, Reiji, et al.
Publicado: (2014)

Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
por: Morishita, Asahiro, et al.
Publicado: (2021)

A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses
por: Barjon, Clément, et al.
Publicado: (2012)

Galectin-9 prolongs the survival of septic mice by expanding tim-3-expressing natural killer T cells and PDCA-1(+) CD11c(+) macrophages
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Carbon monoxide-Releasing Molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats
por: Wei, Yunwei, et al.
Publicado: (2010)

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
por: Hendriks, Mark A. J. M., et al.
Publicado: (2020)

Intracellular Galectin-9 Controls Dendritic Cell Function by Maintaining Plasma Membrane Rigidity
por: Querol Cano, Laia, et al.
Publicado: (2019)

Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9
por: Lhuillier, Claire, et al.
Publicado: (2018)

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
por: Hendriks, Mark A.J.M., et al.
Publicado: (2021)

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells
por: Britsch, Isabel, et al.
Publicado: (2023)

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8(+) T Cell Response
por: Sehrawat, Sharvan, et al.
Publicado: (2010)

Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
por: Chiyo, Taiga, et al.
Publicado: (2019)

Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
por: Abdel-Mohsen, Mohamed, et al.
Publicado: (2016)

The increase of plasma galectin-9 in a patient with insulin allergy: a case report
por: Chagan-Yasutan, Haorile, et al.
Publicado: (2010)

Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017)

A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
por: Mengshol, John A., et al.
Publicado: (2010)

Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo
por: de Bruyn, Marco, et al.
Publicado: (2010)

Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
por: Mengshol, John A., et al.
Publicado: (2010)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

An Automated Approach to Assess Relative Galectin-Glycan Affinity Following Glycan Microarray Analysis
por: Ho, Alex D., et al.
Publicado: (2022)

Glycan Dependence of Galectin-3 Self-Association Properties
por: Halimi, Hubert, et al.
Publicado: (2014)

Galectin-Glycan Interactions as Regulators of B Cell Immunity
por: Giovannone, Nicholas, et al.
Publicado: (2018)

Chemokines modulate glycan binding and the immunoregulatory activity of galectins
por: Sanjurjo, Lucía, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_748u0rqaql01a3if2rv49qarfu